Edwards Lifesciences Corp

VANGUARD GROUP INC EW

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

70,079,435

Value ($000)

5,974,272

Weight

0.1%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	5,974,272	0.1%	70,079,435	12/31/2025
2025 Q3	11/7/2025	5,472,147	0.1%	70,363,210	9/30/2025
2025 Q2	8/11/2025	5,474,515	0.1%	69,997,629	6/30/2025
2025 Q1	5/9/2025	5,015,531	0.1%	69,198,828	3/31/2025
2024 Q4	2/11/2025	5,117,845	0.1%	69,132,036	12/31/2024
2024 Q3	11/13/2024	4,130,614	0.1%	62,594,542	9/30/2024
2024 Q2	8/13/2024	4,948,816	0.1%	53,576,014	6/30/2024
2024 Q1	5/10/2024	5,061,277	0.1%	52,964,394	3/31/2024
2023 Q4	3/11/2024	3,992,709	0.1%	52,363,400	12/31/2023
2023 Q3	12/18/2023	3,577,163	0.1%	51,633,416	9/30/2023
2023 Q2	8/14/2023	4,839,847	0.1%	51,307,608	6/30/2023
2023 Q1	7/14/2023	4,281,379	0.1%	51,751,227	3/31/2023
2022 Q4	2/10/2023	3,846,846	0.1%	51,559,391	12/31/2022
2022 Q3	11/14/2022	4,206,785	0.1%	50,911,104	9/30/2022
2022 Q2	8/12/2022	4,783,677	0.1%	50,306,835	6/30/2022
2022 Q1	5/13/2022	5,853,612	0.1%	49,724,866	3/31/2022
2021 Q4	2/14/2022	6,357,879	0.1%	49,076,649	12/31/2021
2021 Q3	11/12/2021	5,525,402	0.1%	48,806,662	9/30/2021
2021 Q2	8/13/2021	5,003,409	0.1%	48,309,450	6/30/2021
2021 Q1	5/14/2021	4,053,912	0.1%	48,468,576	3/31/2021
2020 Q4	2/12/2021	4,410,760	0.1%	48,347,685	12/31/2020
2020 Q3	11/16/2020	3,898,507	0.1%	48,841,226	9/30/2020
2020 Q2	8/14/2020	3,416,005	0.1%	49,428,510	6/30/2020
2020 Q1	5/15/2020	3,145,613	0.1%	16,676,985	3/31/2020
2019 Q4	2/14/2020	3,793,692	0.1%	16,261,702	12/31/2019
2014 Q2	8/11/2014	637,592	0.1%	7,427,673	6/30/2014
2014 Q1	5/13/2014	552,819	0.0%	7,453,402	3/31/2014
2013 Q4	2/12/2014	484,088	0.0%	7,361,439	12/31/2013